Systemic inflammation, genetic susceptibility and lung function

European Respiratory Journal

Volumn 32, Issue 1, 2008, Pages 92-97

  Sunyer, J ^a,b   Pistelli, R ^c   Plana, E ^a   Andreani, M ^c   Baldari, F ^c   Kolz, M ^e   Koenig, W ^f   Pekkanen, J ^g   Peters, A ^e   Forastiere, F ^d  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c CATHOLIC UNIVERSITY   (Italy)

^d LocalHealth Authority   (Italy)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY HOSPITAL ULM   (Germany)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

C reactive protein; Genes; Lung function; Mendelian randomisation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; INFLAMMATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPIROMETRY; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; LUNG FUNCTION TEST; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADULT; AGED; C-REACTIVE PROTEIN; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFLAMMATION; INTERLEUKIN-6; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS;

EID: 52749091857     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00052507     Document Type: Article

References (28)

1. Pawels R, Rabe K. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620.
2. Sin DD, Man SF. Commentary: fuelling the fire-systemic inflammation and development of lung disease in the general community. Int J Epidemiol 2006; 35: 1008-1010.
3. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1008-1011.
4. Engström G, Lind P, Hedblad B, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555-2560.
5. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003; 114: 758-762.
6. Gan WQ, Man SF, Sin DD. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 2005; 127: 558-564.
7. Kony S, Zureik M, Driss F, Neurkirch C, Leynaert B, Neurkirch F. Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study. Thorax 2004; 59: 892-896.
8. Aronson D, Roterman I, Yigla M, et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 2006; 174: 626-632.
9. Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 2007; 62: 515-520.
10. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-1519.
11. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
12. VM Pinto-Plata, Müllerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and nonsmokers. Thorax 2006; 61: 23-28.
13. Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD. Plasma fibrinogen and lung function: the CARDIA Study. Int J Epidemiol 2006; 35: 1001-1008.
14. Timpson NJ, Lawlor DA, Harbord RM, et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 2005; 366: 1954-1959.
15. Yanbaeva DG, Dentener MA, Creutzberg EC, Wouters EF. Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD 2006; 3: 51-61.
16. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
17. Peters A, Schneider A, Greven S, et al. Air pollution and inflammatory response in myocardial infarction survivors: gene-environment- interactions in a high-risk group. Inhal Toxicol 2007; 19: Suppl. 1, 161-175.
18. SeattleSNPS Variation Discovery Resource. http://pga.gs.washington.edu/ Date last accessed: March 2006. Date last updated: March 2006.
19. BLAT Search Genome. http://genome.ucsc.edu/cgi-bin/hgBlat Date last accessed: March 2006. Date last updated: March 2006.
20. Weidinger S, Klopp N, Wagenpfeil S, et al. Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 2004; 41: 658-663.
21. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables. Aplications and limitations. Epidemiology 2006; 17: 260-267.
22. Davey Smith G, Lawlor DA, Harbord R, et al. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 2005; 25: 1051-1056.
23. Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JC. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J 2006; 27: 1331-1337.
24. Russell AI, Cunninghame Graham DS, Shepherd C, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004; 13: 137-147.
25. Miller DT, Zee RY, Suk Danik J, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005; 69: 623-638.
26. Kolz M, Koening W, Müller M, et al. DNA variants, plasma levels and variability of C-reactive protein in myocardial infaction survivors: results from the AIRGENE study. Kongress Medizin und Gesellschaft, 2007. www.egms.de/en/meetings/gmds2007/07gmds205.shtml.
27. Block G, Dietrich M, Norkus E, et al. Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology 2006; 17: 404-412.
28. Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005; 330: 1076-1079.